Amlodipine
Brand names: Istin, Amlodip
Amlodipine is a long-acting dihydropyridine calcium-channel blocker used for hypertension and chronic stable and vasospastic angina.
Adult dose
Dose adjustments
Changes in amlodipine plasma concentrations are not correlated with the degree of renal impairment, therefore the normal dosage is recommended. Amlodipine is not dialysable.
Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC; US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
Contraindications
- Hypersensitivity to dihydropyridine derivatives, amlodipine or to any of the excipients
- Severe hypotension
- Shock (including cardiogenic shock)
- Obstruction of the outflow tract of the left ventricle (e.g. high grade aortic stenosis)
- Haemodynamically unstable heart failure after acute myocardial infarction
Side effects
- Very common: oedema
- Common: somnolence, dizziness, headache (especially at the beginning of treatment)
- Common: palpitations; flushing
- Common: abdominal pain, nausea, dyspepsia, altered bowel habits (including diarrhoea and constipation)
- Common: ankle swelling, muscle cramps; fatigue, asthenia; dyspnoea; visual disturbance (including diplopia)
- Uncommon / very rare: hypotension, arrhythmia (including bradycardia, ventricular tachycardia and atrial fibrillation), myocardial infarction, hepatitis and jaundice, gingival hyperplasia, angioedema, Stevens-Johnson syndrome, and (not known) toxic epidermal necrolysis
Interactions
- Strong or moderate CYP3A4 inhibitors (protease inhibitors, azole antifungals, macrolides such as erythromycin or clarithromycin, verapamil, diltiazem) — may give a significant increase in amlodipine exposure and an increased risk of hypotension, more pronounced in the elderly; clinical monitoring and dose adjustment may be required
- CYP3A4 inducers (e.g. rifampicin, Hypericum perforatum / St John's wort) — plasma concentration of amlodipine may vary; monitor blood pressure and consider dose regulation during and after concomitant use
- Grapefruit or grapefruit juice — administration with amlodipine is not recommended as bioavailability may be increased in some patients, resulting in increased blood-pressure-lowering effects
- Dantrolene (infusion) — in animals, lethal ventricular fibrillation and cardiovascular collapse were observed in association with hyperkalaemia after verapamil and intravenous dantrolene; because of the risk of hyperkalaemia, co-administration of calcium channel blockers is not recommended (the fetched §4.5 is truncated at this point)
Clinical monograph
How it works
It blocks L-type calcium channels in vascular smooth muscle, causing peripheral and coronary arterial vasodilatation that lowers blood pressure and reduces myocardial oxygen demand.
Prescribing in practice
- Avoid in cardiogenic shock, significant aortic stenosis and unstable angina, and use cautiously in severe hypotension.
- Dose-related ankle oedema is common and reflects vasodilatation rather than fluid overload, so diuretics are not the appropriate response.
- Exposure is increased in hepatic impairment and by potent CYP3A4 inhibitors, warranting cautious dosing.
Monitoring
Monitor blood pressure and review for peripheral oedema and any anginal symptom change.
Counselling the patient
- Ankle swelling and flushing or headache may occur, often easing with time.
- Avoid grapefruit juice, which can increase the drug's effect.
Evidence & guidelines
Large outcome trials support dihydropyridine calcium-channel blockers such as amlodipine as effective first-line antihypertensive therapy.
Reference: ACCOMPLISH Trial; BSR/BHPR Guidelines on Raynaud's Phenomenon; NICE NG136 (Hypertension); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Rate-Pressure Product (RPP) · Haemodynamics
- DAPT Score · Coronary Artery Disease
- Mehran Score for Post-PCI Contrast Nephropathy · Coronary Artery Disease
- Aortic Dissection Detection Risk Score (ADD-RS) · Aortic Disease
- RoPE Score for Patent Foramen Ovale · Structural Heart Disease
- Canadian Cardiovascular Society (CCS) Angina Grading · Coronary Artery Disease